Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Sep 1;350(Pt 2):599–608.

Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.

J R Dyck 1, L G Berthiaume 1, P D Thomas 1, P F Kantor 1, A J Barr 1, R Barr 1, D Singh 1, T A Hopkins 1, N Voilley 1, M Prentki 1, G D Lopaschuk 1
PMCID: PMC1221289  PMID: 10947976

Abstract

In the liver, malonyl-CoA is central to many cellular processes, including both fatty acid biosynthesis and oxidation. Malonyl-CoA decarboxylase (MCD) is involved in the control of cellular malonyl-CoA levels, and functions to decarboxylate malonyl-CoA to acetyl-CoA. MCD may play an essential role in regulating energy utilization in the liver by regulating malonyl-CoA levels in response to various nutritional or pathological states. The purpose of the present study was to investigate the role of liver MCD in the regulation of fatty acid oxidation in situations where lipid metabolism is altered. A single MCD enzyme of molecular mass 50.7 kDa was purified from rat liver using a sequential column chromatography procedure and the cDNA was subsequently cloned and sequenced. The liver MCD cDNA was identical to rat pancreatic beta-cell MCD cDNA, and contained two potential translational start sites, producing proteins of 50.7 kDa and 54.7 kDa. Western blot analysis using polyclonal antibodies generated against rat liver MCD showed that the 50.7 kDa isoform of MCD is most abundant in heart and liver, and of relatively low abundance in skeletal muscle (despite elevated MCD transcript levels in skeletal muscle). Tissue distribution experiments demonstrated that the pancreas is the only rat tissue so far identified that contains both the 50.7 kDa and 54. 7 kDa isoforms of MCD. In addition, transfection of the full-length rat liver MCD cDNA into COS cells produced two isoforms of MCD. This indicated either that both initiating methionines are functionally active, generating two proteins, or that the 54.7 kDa isoform is the only MCD protein translated and removal of the putative mitochondrial targeting pre-sequence generates a protein of approx. 50.7 kDa in size. To address this, we transiently transfected a mutated MCD expression plasmid (second ATG to GCG) into COS-7 cells and performed Western blot analysis using our anti-MCD antibody. Western blot analysis revealed that two isoforms of MCD were still present, demonstrating that the second ATG may not be responsible for translation of the 50.7 kDa isoform of MCD. These data also suggest that the smaller isoform of MCD may originate from intracellular processing. To ascertain the functional role of the 50. 7 kDa isoform of rat liver MCD, we measured liver MCD activity and expression in rats subjected to conditions which are known to alter fatty acid metabolism. The activity of MCD was significantly elevated under conditions in which hepatic fatty acid oxidation is known to increase, such as streptozotocin-induced diabetes or following a 48 h fast. A 2-fold increase in expression was observed in the streptozotocin-diabetic rats compared with control rats. In addition, MCD activity was shown to be enhanced by alkaline phosphatase treatment, suggesting phosphorylation-related control of the enzyme. Taken together, our data demonstrate that rat liver expresses a 50.7 kDa form of MCD which does not originate from the second methionine of the cDNA sequence. This MCD is regulated by at least two mechanisms (only one of which is phosphorylation), and its activity and expression are increased under conditions where fatty acid oxidation increases.

Full Text

The Full Text of this article is available as a PDF (255.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam N., Saggerson E. D. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle. Biochem J. 1998 Aug 15;334(Pt 1):233–241. doi: 10.1042/bj3340233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bird M. I., Saggerson E. D. Binding of malonyl-CoA to isolated mitochondria. Evidence for high- and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity. Biochem J. 1984 Sep 15;222(3):639–647. doi: 10.1042/bj2220639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarke S. D., Armstrong M. K., Jump D. B. Nutritional control of rat liver fatty acid synthase and S14 mRNA abundance. J Nutr. 1990 Feb;120(2):218–224. doi: 10.1093/jn/120.2.218. [DOI] [PubMed] [Google Scholar]
  4. Courchesne-Smith C., Jang S. H., Shi Q., DeWille J., Sasaki G., Kolattukudy P. E. Cytoplasmic accumulation of a normally mitochondrial malonyl-CoA decarboxylase by the use of an alternate transcription start site. Arch Biochem Biophys. 1992 Nov 1;298(2):576–586. doi: 10.1016/0003-9861(92)90452-3. [DOI] [PubMed] [Google Scholar]
  5. Dyck J. R., Barr A. J., Barr R. L., Kolattukudy P. E., Lopaschuk G. D. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol. 1998 Dec;275(6 Pt 2):H2122–H2129. doi: 10.1152/ajpheart.1998.275.6.H2122. [DOI] [PubMed] [Google Scholar]
  6. Elayan I. M., Cartmill D. C., Eckersell C. B., Wilkin J., Winder W. W. Malonyl-CoA in skeletal muscle and liver of streptozotocin-diabetic rats. Proc Soc Exp Biol Med. 1991 Oct;198(1):569–571. doi: 10.3181/00379727-198-43290. [DOI] [PubMed] [Google Scholar]
  7. Espeel M., Van Limbergen G. Immunocytochemical localization of peroxisomal proteins in human liver and kidney. J Inherit Metab Dis. 1995;18 (Suppl 1):135–154. doi: 10.1007/BF00711436. [DOI] [PubMed] [Google Scholar]
  8. Gao J., Waber L., Bennett M. J., Gibson K. M., Cohen J. C. Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase. J Lipid Res. 1999 Jan;40(1):178–182. [PubMed] [Google Scholar]
  9. Jang S. H., Cheesbrough T. M., Kolattukudy P. E. Molecular cloning, nucleotide sequence, and tissue distribution of malonyl-CoA decarboxylase. J Biol Chem. 1989 Feb 25;264(6):3500–3505. [PubMed] [Google Scholar]
  10. Katsurada A., Iritani N., Fukuda H., Matsumura Y., Nishimoto N., Noguchi T., Tanaka T. Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of fatty acid synthase in rat liver. Eur J Biochem. 1990 Jun 20;190(2):427–433. doi: 10.1111/j.1432-1033.1990.tb15592.x. [DOI] [PubMed] [Google Scholar]
  11. Kim T. S., Freake H. C. High carbohydrate diet and starvation regulate lipogenic mRNA in rats in a tissue-specific manner. J Nutr. 1996 Mar;126(3):611–617. doi: 10.1093/jn/126.3.611. [DOI] [PubMed] [Google Scholar]
  12. Kolattukudy P. E., Poulose A. J., Kim Y. S. Malonyl-CoA decarboxylase from avian, mammalian, and microbial sources. Methods Enzymol. 1981;71(Pt 100):150–163. doi: 10.1016/0076-6879(81)71022-x. [DOI] [PubMed] [Google Scholar]
  13. Lopaschuk G. D., Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res. 1989 Aug;65(2):378–387. doi: 10.1161/01.res.65.2.378. [DOI] [PubMed] [Google Scholar]
  14. Louis N. A., Witters L. A. Glucose regulation of acetyl-CoA carboxylase in hepatoma and islet cells. J Biol Chem. 1992 Feb 5;267(4):2287–2293. [PubMed] [Google Scholar]
  15. Mathé D. Dyslipidemia and diabetes: animal models. Diabete Metab. 1995 Apr;21(2):106–111. [PubMed] [Google Scholar]
  16. McGarry J. D., Brown N. F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem. 1997 Feb 15;244(1):1–14. doi: 10.1111/j.1432-1033.1997.00001.x. [DOI] [PubMed] [Google Scholar]
  17. McGarry J. D., Takabayashi Y., Foster D. W. The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J Biol Chem. 1978 Nov 25;253(22):8294–8300. [PubMed] [Google Scholar]
  18. Miethke H., Wittig B., Nath A., Jungermann K. Gluconeogenic-glycolytic capacities and metabolic zonation in liver of rats with streptozotocin, non-ketotic as compared to alloxan, ketotic diabetes. Histochemistry. 1986;85(6):483–489. doi: 10.1007/BF00508430. [DOI] [PubMed] [Google Scholar]
  19. Moir A. M., Zammit V. A. Effects of insulin treatment of diabetic rats on hepatic partitioning of fatty acids between oxidation and esterification, phospholipid and acylglycerol synthesis, and on the fractional rate of secretion of triacylglycerol in vivo. Biochem J. 1994 Nov 15;304(Pt 1):177–182. doi: 10.1042/bj3040177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ozcelikay A. T., Becker D. J., Ongemba L. N., Pottier A. M., Henquin J. C., Brichard S. M. Improvement of glucose and lipid metabolism in diabetic rats treated with molybdate. Am J Physiol. 1996 Feb;270(2 Pt 1):E344–E352. doi: 10.1152/ajpendo.1996.270.2.E344. [DOI] [PubMed] [Google Scholar]
  21. Porter J. W., Swenson T. L. Induction of fatty acid synthetase and acetyl-CoA carboxylase by isolated rat liver cells. Mol Cell Biochem. 1983;53-54(1-2):307–325. doi: 10.1007/BF00225262. [DOI] [PubMed] [Google Scholar]
  22. Russell J. C., Graham S., Hameed M. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism. 1994 May;43(5):538–543. doi: 10.1016/0026-0495(94)90192-9. [DOI] [PubMed] [Google Scholar]
  23. Sacksteder K. A., Morrell J. C., Wanders R. J., Matalon R., Gould S. J. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency. J Biol Chem. 1999 Aug 27;274(35):24461–24468. doi: 10.1074/jbc.274.35.24461. [DOI] [PubMed] [Google Scholar]
  24. Sherwin J. E., Natelson S. Serum and erythocyte argininosuccinate lyase assay by NADH fluorescence generated from formed fumarate. Clin Chem. 1975 Feb;21(2):230–234. [PubMed] [Google Scholar]
  25. Shillabeer G., Hornford J., Forden J. M., Wong N. C., Russell J. C., Lau D. C. Fatty acid synthase and adipsin mRNA levels in obese and lean JCR:LA-cp rats: effect of diet. J Lipid Res. 1992 Jan;33(1):31–39. [PubMed] [Google Scholar]
  26. Topping D. L., Targ M. E. Time-course of changes in blood glucose and ketone bodies, plasma lipids and liver fatty acid composition in streptozotocin-diabetic male rats. Horm Res. 1975;6(3):129–137. doi: 10.1159/000178670. [DOI] [PubMed] [Google Scholar]
  27. Voilley N., Roduit R., Vicaretti R., Bonny C., Waeber G., Dyck J. R., Lopaschuk G. D., Prentki M. Cloning and expression of rat pancreatic beta-cell malonyl-CoA decarboxylase. Biochem J. 1999 May 15;340(Pt 1):213–217. [PMC free article] [PubMed] [Google Scholar]
  28. Vydelingum S., Shillabeer G., Hatch G., Russell J. C., Lau D. C. Overexpression of the obese gene in the genetically obese JCR:LA-corpulent rat. Biochem Biophys Res Commun. 1995 Nov 2;216(1):148–153. doi: 10.1006/bbrc.1995.2603. [DOI] [PubMed] [Google Scholar]
  29. Witters L. A., Gao G., Kemp B. E., Quistorff B. Hepatic 5'-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch Biochem Biophys. 1994 Feb 1;308(2):413–419. doi: 10.1006/abbi.1994.1058. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES